Polyrizon Ltd. - Ordinary Shares (NQ:PLRZ)
All News about Polyrizon Ltd. - Ordinary Shares
Polyrizon Submits Pre-Sub Package to the FDA for PL-14 Allergy Blocker
September 19, 2025
From Polyrizon Ltd.
Via GlobeNewswire
Polyrizon Reports Successful Intranasal Delivery of PL-14 Allergy Blocker in Latest Study
September 12, 2025
From Polyrizon Ltd.
Via GlobeNewswire
Polyrizon Regains Compliance with Nasdaq Listing Requirements
August 14, 2025
From Polyrizon Ltd.
Via GlobeNewswire